175 related articles for article (PubMed ID: 30585800)
1. Editorial: Omega-3 fatty acids and cardiovascular outcomes: an update.
Calder PC; Deckelbaum RJ
Curr Opin Clin Nutr Metab Care; 2019 Mar; 22(2):97-102. PubMed ID: 30585800
[No Abstract] [Full Text] [Related]
2. Omega-3 fatty acids: recommendations for therapeutics and prevention.
Hutchins H; Vega CP
MedGenMed; 2005 Oct; 7(4):18. PubMed ID: 16614640
[No Abstract] [Full Text] [Related]
3. Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.
Cao Y; Lu L; Liang J; Liu M; Li X; Sun R; Zheng Y; Zhang P
Cell Biochem Biophys; 2015 May; 72(1):77-81. PubMed ID: 25427890
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids and secondary prevention of cardiovascular disease-is it just a fish tale?: comment on “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease”.
Hu FB; Manson JE
Arch Intern Med; 2012 May; 172(9):694-6. PubMed ID: 22493410
[No Abstract] [Full Text] [Related]
5. Using omega-3 fatty acids in the practice of clinical lipidology.
Brown WV; Bays H; Harris W; Miller M
J Clin Lipidol; 2011; 5(6):424-33. PubMed ID: 22108145
[No Abstract] [Full Text] [Related]
6. N-3 fatty acids: priority for post-myocardial infarction clinical trials.
Grundy SM
Circulation; 2003 Apr; 107(14):1834-6. PubMed ID: 12695281
[No Abstract] [Full Text] [Related]
7. [The role of omega-fatty acids in cardiovascular prevention].
Rumboldt Z
Lijec Vjesn; 2009; 131(3-4):103-4. PubMed ID: 19514259
[No Abstract] [Full Text] [Related]
8. Secondary cardiovascular prevention: omega-3 fatty acids ineffective.
Prescrire Int; 2013 Sep; 22(141):218. PubMed ID: 24171221
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of cardiovascular diseases with omega-3-fatty acids and vitamins?].
Musch A
Med Monatsschr Pharm; 2006 Mar; 29(3):109. PubMed ID: 16550885
[No Abstract] [Full Text] [Related]
10. Omega-3 fatty acid supplementation and cardiovascular disease events.
Galli C; Brenna JT
JAMA; 2013 Jan; 309(1):28-9. PubMed ID: 23280211
[No Abstract] [Full Text] [Related]
11. Omega-3 fatty acid supplementation and cardiovascular disease events.
Vlachopoulos C; Richter D; Stefanadis C
JAMA; 2013 Jan; 309(1):28. PubMed ID: 23280210
[No Abstract] [Full Text] [Related]
12. Omega-3 fatty acid supplementation and cardiovascular disease events.
Sethi A; Singh M; Arora R
JAMA; 2013 Jan; 309(1):27-8. PubMed ID: 23280209
[No Abstract] [Full Text] [Related]
13. Omega-3 fatty acid supplementation and cardiovascular disease events.
Lewis EJ
JAMA; 2013 Jan; 309(1):27. PubMed ID: 23280208
[No Abstract] [Full Text] [Related]
14. Omega-3 fatty acid supplementation and cardiovascular disease events--reply.
Rizos EC; Ntzani EE; Elisaf MS
JAMA; 2013 Jan; 309(1):29. PubMed ID: 23280212
[No Abstract] [Full Text] [Related]
15. A fishy business: omega-3 fatty acids and cardiovascular disease.
Wierzbicki AS
Int J Clin Pract; 2008 Aug; 62(8):1142-6. PubMed ID: 18705819
[No Abstract] [Full Text] [Related]
16. [Omega-3 fatty acids have proven effects on the heart--the impact of GISSI-HF trial].
Reiner Z
Lijec Vjesn; 2009; 131(1-2):42-3. PubMed ID: 19348356
[No Abstract] [Full Text] [Related]
17. Omega-3 Fatty Acid Supplements and Risk of CHD.
Rosenberg K
Am J Nurs; 2018 May; 118(5):69. PubMed ID: 29698285
[No Abstract] [Full Text] [Related]
18. Omega-3 (n-3) fatty acids in health and disease: Part 1--cardiovascular disease and cancer.
Shahidi F; Miraliakbari H
J Med Food; 2004; 7(4):387-401. PubMed ID: 15671680
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids in food and pharma: the enabling role of biotechnology.
Gillies PJ; Harris WS; Kris-Etherton PM
Curr Atheroscler Rep; 2011 Dec; 13(6):467-73. PubMed ID: 21892757
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease.
von Schacky C
Evid Based Med; 2013 Aug; 18(4):e33. PubMed ID: 23161504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
